FOR RESEARCH & DEVELOPMENT USE ONLY • NOT FOR HUMAN OR VETERINARY USE

Growth Factors & Secretagogues

Scientific information

Growth Factors & Secretagogues

This family focuses on experimental control of the growth-hormone and IGF signalling axis, including release patterns, receptor activity and downstream biomarkers.

01

Research overview

This family focuses on experimental control of the growth-hormone and IGF signalling axis, including release patterns, receptor activity and downstream biomarkers.

02

Current research directions

  • Pulsatile versus sustained growth-hormone release and the resulting endocrine response.
  • Relationships between GH-releasing pathways, IGF signalling, body composition and metabolic markers.
  • Pharmacokinetic and receptor-selectivity studies used to compare short- and long-acting research analogues.
03

Evidence landscape

Mixed evidence

Some pathways have controlled human data, while others remain supported mainly by early clinical or mechanistic studies.

04

Research compounds represented

The following compounds are grouped within this research family according to the current OTAG catalogue. Presentations describe catalogue specifications only and do not establish clinical use.

CJC-1295 with DAC

Research compound
Available presentations
5 mg 10 mg
Catalogue formats Individual vial and sealed box of 10 vials

CJC-1295 without DAC

Research compound
Available presentations
5 mg 10 mg
Catalogue formats Individual vial and sealed box of 10 vials

GHRP-2 Acetate

Research compound
Available presentations
5 mg 10 mg
Catalogue formats Individual vial and sealed box of 10 vials

GHRP-6 Acetate

Research compound
Available presentations
5 mg 10 mg
Catalogue formats Individual vial and sealed box of 10 vials

IGF-1 LR3

Research compound
Available presentations
0.1 mg 1 mg
Catalogue formats Individual vial and sealed box of 10 vials

Ipamorelin

Research compound
Available presentations
5 mg 10 mg
Catalogue formats Individual vial and sealed box of 10 vials

Sermorelin Acetate

Research compound
Available presentations
5 mg 10 mg
Catalogue formats Individual vial and sealed box of 10 vials

Tesamorelin

Research compound
Available presentations
5 mg 10 mg 20 mg
Catalogue formats Individual vial and sealed box of 10 vials

Catalogue information is provided for laboratory identification and research planning. No dosage, administration or clinical-use guidance is provided.

← All research areas